BACKGROUND:
Betatrophin has been reported to have a role in beta cell talk about insulin resistance states. Betatrophin levels association with gestational diabetes mellitus (GDM) in comparison to normal glucose tolerance need to be evaluated.
AIM OF THE STUDY:
Assessment of betatrophin level in pregnant women with gestational diabetes in comparison to those with no gestational diabetes.
PATIENTS AND METHODS:
Case control study .The study included 100 pregnant women divided in to 2 groups.
1st group –included 50 pregnant women diagnosed to have GDM.
2nd group –included 50 pregnant women with no GDM as control group.
For all included women measurement of maternal serum betatrophin level was performed.
RESULTS:
The Mean ±SD of betatrophin in women with GDM was (295.78 pg/ml ±193.03pg/ml) and in control group was (157.04 pg/ml ±77.62pg/ml) it was significantly higher in association with GDM at p value <0.001. In GDM, betatrophin level were significantly correlated with maternal age, parity, HbA1c(r=0.455, p=0.001), (r=0.413, p=0.003), (r=0.287, p=0.044) respectively. No significant correlation with BMI (r=0.163, p=0.258) nor with gestational age (r=0.065, p=0.654). ROC curve for betatrophin level as diagnostic aid for GDM demonstrated that AUC was 0.692 at p value 0.001, sensitivity 62.0%, specifity 66.0% cutoff value 185.5 ng/ml.
CONCLUSION:
Betatrophin is significantly higher in pregnant women who have gestational diabetes in comparison with normal healthy pregnant women and it is significantly correlated with maternal age, parity, and HbA1c.
|
- Gary F, Cunningham et al. "Williams's obstetrics" New York: MC Graw Hill medical companies 25rd. 2018; ch57: 3072-2455.
- Luesley D, Baker P, et al. (Obstetrics and Gynaecology) an evidence- base- text for MRCOG 3nd edition. 2016; ch (9): 68.
- Backer P, Kenny L, et al. Obstetrics by Ten Teachers 20th edition edit. 2017; Ch (10): 309.
- Sarah N, Dornhorst AA. Diabetes in pregnancy .Dewhurst textbook of Obestetric and gynecology Ninth edition . 2018; ch 9:100.
- Zhao P, Liu E, Qiao Y et al. Maternal gestational diabetes and childhood obesity at age 9–11: results of a multinational study. Diabetologia .2016; 59:2339–48.
- Rani PR, Begum J. Screening and Diagnosis of Gestational Diabetes Mellitus. Where Do We Stand? 2016; 10:1-4.
- Susanto H,et al. Betatrophin/Lipasin/C19orf80: In Silico Approach for Protein-Based Biomaterial Marker in Metabolic Syndrome and Colorectal Cancer Through Computational-Based Study. IOP Conference Series: Materials Science and Engineering. 2019;515:
- Zhang R, Abou-Samra AB. A dual role of lipasin (betatrophin in lipid metabolism and glucose homeostasis: consensus and controversy. J of Cardio Vascular Diabetology. 2014;13:133.
- Chene Y,Zhang YZ, et al.Identification of genes differentially expressed in human hepatocellular carcinoma by a modified suppression subtractive hybridization method. Int. J. Cancer .2004; 112: 239–48.
- Yi P, Park JS, and Melton DA. Betatrophin: A Hormone that Controls Pancreatic β Cell Proliferation .Cell.2013;153: 747-58.
- .Kassem SA, Ariel I, Thornton PS, Scheimberg I, Glaser B. Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes. 2000;49:1325-33.
- Kugelberg E. Diabetes: Betatrophin-inducing beta-cell expansion to treat diabetes mellitus. Nat Rev Endocrinol .2013; 9:379.
- Crunkhorn S. Metabolic disorders: Betatrophin boosts beta-cells. Nat Rev Drug Discov. 2013; 12:504.
- Yi P, Park JS, Melton DA. Betatrophin: a hormone that controls pancreatic beta cell proliferation. Cell. 2013; 153:747-58.
- Pan P, Zhang H, and Yu S. Betatrophin for diagnosis and prognosis of mothers with gestational diabetes mellitus. Journal of International Medical Research. 2019; 47: 710–17.
- Juan Kong F, Lei Ma L, et al .Circulating Betatrophin Levels and Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis. PLoS One. 2017; 12: e0169941.
- Erol O, Ellidag HY, Ayik H, Ozel MK, Derbent AU, and Yilmaz N. Evaluation of circulating betatrophin levels in gestational diabetes mellitus. Gynecol Endocrinol. 2015; 31:652–56.
- Juan Kong F, Lei Ma L, et al. Changes and clinical significance of Betatrophin level in plasma and cord blood in pregnant women with gestational diabetes mellitus. Hainan Medical Journal. 2016;7:1070–72.
- Huang Y, Fang C, Ma Z, et al. Betatrophin Levels were Increased in Pregnant Women with or without Gestational Diabetes Mellitus and Associated with Beta Cell Function. Rev Bras Ginecol Obstet 2016; 38:287–92.
- .Fenzl A, Itariu BK, Kosi L, Fritzer-Szekeres M, Kautzky-Willer A, Stulnig TM, et al. Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals. Diabetologia. 2014;57:1204–8.
- Yilmaz H, Cakmak M, Darcin T, Demir C, Inan O, Ceydilek B, et al. Retraction: elevated plasma levels of betatrophin in women with gestational diabetes mellitus. Experimental & Clinical Endocrinology & Diabetes. 2015;123:376–81.
- Takebayashi K, Hara K, et al. Serum Betatrophin Levels and Clinical Features in Patients With Poorly Controlled Type 2 Diabetes J Clin Med Res. 2017;9:782-87.
- Chen X, Lu P, He W, et al. Circulating betatrophin levels are increased in patients with type 2 diabetes and associated with insulin resistance. J Clinl Endocrinol Metab 2015; 100: E96–E100.
- Zheng J, Liu J,et al.Circulating betatrophin/ANGPTL8 levels correlate with body fat distribution in individuals with normal glucose tolerance but not those with glucose disorders BMC Endocrine. Disorder.2017; 49:343–49.
- Abu-Farha M, Sriraman D, Cherian P, et al. Circulating ANGPTL8/Betatrophin Is Increased in Obesity and Reduced after Exercise Training. PloS one .2016;11:
|
